Paper574053
Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.
Björklund A and 1 other. Brain Res, 1979. Cited by 689 papers, by iCite.
Cite this record
ConductScience Library. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Papers, record 574053. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/574053
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Corpus Striatum | Major topic |
| Dopamine | Major topic |
| Nerve Regeneration | Major topic |
| Substantia Nigra | Major topic |
| Animals | |
| Female | |
| Humans | |
| Hydroxydopamines | |
| Methamphetamine | |
| Neural Pathways | |
| Parietal Lobe | |
| Rats | |
| Stereotyped Behavior |
Source PubMed
Cited by137
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 689 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42076911 | Homogenous Cell Transplantation Trials in Parkinson's Disease: A Systematic Review and Meta-Analysis. | Mov Disord Clin Pract | 2026 | https://conductscience.org/library/papers/42076911 | PubMed |
| 41972669 | Bridging Regenerative and Restorative Stem Cell Therapies in Parkinson's Disease. | Cells | 2026 | https://conductscience.org/library/papers/41972669 | PubMed |
| 41425946 | Automated thermal gradient test for unprovoked assessment of nociceptive preference in rodents. | Front Behav Neurosci | 2025 | https://conductscience.org/library/papers/41425946 | PubMed |
| 40346597 | Electrophysiological characterisation of intranigral-grafted hiPSC-derived dopaminergic neurons in a mouse model of Parkinson's disease. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40346597 | PubMed |
| 39058892 | The history and status of dopamine cell therapies for Parkinson's disease. | Bioessays | 2024 | https://conductscience.org/library/papers/39058892 | PubMed |
| 38472261 | Possible role of lncRNAs in amelioration of Parkinson's disease symptoms by transplantation of dopaminergic cells. | NPJ Parkinsons Dis | 2024 | https://conductscience.org/library/papers/38472261 | PubMed |
| 38457149 | Dopaminergic Cell Replacement for Parkinson's Disease: Addressing the Intracranial Delivery Hurdle. | J Parkinsons Dis | 2024 | https://conductscience.org/library/papers/38457149 | PubMed |
| 38137103 | Cell Replacement Therapy for Brain Repair: Recent Progress and Remaining Challenges for Treating Parkinson's Disease and Cortical Injury. | Brain Sci | 2023 | https://conductscience.org/library/papers/38137103 | PubMed |
| 37886394 | Challenges involved in cell therapy for Parkinson's disease using human pluripotent stem cells. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37886394 | PubMed |
| 37679754 | Cell-therapy for Parkinson's disease: a systematic review and meta-analysis. | J Transl Med | 2023 | https://conductscience.org/library/papers/37679754 | PubMed |
| 37285828 | Parkinson's Disease: A Tale of Many Players. | Med Princ Pract | 2023 | https://conductscience.org/library/papers/37285828 | PubMed |
| 37185323 | Neuronal Vulnerability to Degeneration in Parkinson's Disease and Therapeutic Approaches. | CNS Neurol Disord Drug Targets | 2024 | https://conductscience.org/library/papers/37185323 | PubMed |
| 36653531 | Development, wiring and function of dopamine neuron subtypes. | Nat Rev Neurosci | 2023 | https://conductscience.org/library/papers/36653531 | PubMed |
| 35204840 | Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis. | Biomolecules | 2022 | https://conductscience.org/library/papers/35204840 | PubMed |
| 34541106 | Transplantation of Embryonic Cortical Tissue into Lesioned Adult Brain in Mice. | Bio Protoc | 2017 | https://conductscience.org/library/papers/34541106 | PubMed |
| 34055800 | Postmortem Studies of Fetal Grafts in Parkinson's Disease: What Lessons Have We Learned? | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34055800 | PubMed |
| 33919317 | Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33919317 | PubMed |
| 33298940 | Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease. | NPJ Regen Med | 2020 | https://conductscience.org/library/papers/33298940 | PubMed |
| 33177975 | Current Status of Stem Cell-Derived Therapies for Parkinson's Disease: From Cell Assessment and Imaging Modalities to Clinical Trials. | Front Neurosci | 2020 | https://conductscience.org/library/papers/33177975 | PubMed |
| 33101007 | On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson's and Huntington's Disease. | Front Aging Neurosci | 2020 | https://conductscience.org/library/papers/33101007 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/574053
GET https://conductscience.org/api/papers/v1/574053/cited_by?page=2